Plain-English translation of NCT06979427 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing whether a special type of heart scan — called CT-FFR — can accurately predict which moderate coronary artery blockages (narrowings of 50-70%) are safe and don't need treatment. This study follows 250 patients for one year to see if those with "safe" blockages stay healthy without needing emergency procedures or hospitalization.
Many patients have moderate blockages in their heart arteries, but doctors don't always know which ones will cause problems. This study aims to help doctors avoid unnecessary procedures while keeping patients safe from serious heart events.
You likely qualify if…
You likely don't qualify if…
You would have already completed the heart scans (CT angiography and FFR testing) needed for the study. After enrollment, you'll be monitored for one year with check-in visits every three months and phone calls in between to track your health and any heart-related events. Researchers will watch for serious complications like heart attacks, emergency procedures, or hospitalizations.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Iran
Shiraz University of Medical Sciences
Enrollment target
~250 participants
Started
January 2024
Primary completion
July 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
20 Years – 80 Years
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
javad UOM kojuri
Shiraz University of Medical Sciences
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.